Given the prior body of evidence that pointed towards GABPA being a key regulator of mutant TERT promoter in glioblastoma, the effect of GABPA knockdown on TERT expression was further tested across a comprehensive range of thyroid cell lines harboring wild-type TERT promoter sequences and heterozygous or homozygous TPMs. The gene discussed is GABPA; the disease is glioblastoma.